Chan SL - Search Results

1

Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis.

Chan SL, Chan-Yeung MM, Ooi GC, Lam CL, Cheung TF, Lam WK, Tsang KW. Chan SL, et al. Among authors: chan yeung mm. Chest. 2002 Dec;122(6):2030-7. doi: 10.1378/chest.122.6.2030. Chest. 2002. PMID: 12475843

2

Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters.

Tsang KW, Leung R, Fung PC, Chan SL, Tipoe GL, Ooi GC, Lam WK. Tsang KW, et al. Among authors: chan sl. Chest. 2002 Jan;121(1):88-94. doi: 10.1378/chest.121.1.88. Chest. 2002. PMID: 11796436

3

Noninvasive ventilatory support during sleep improves respiratory failure in kyphoscoliosis.

Ellis ER, Grunstein RR, Chan S, Bye PT, Sullivan CE. Ellis ER, et al. Chest. 1988 Oct;94(4):811-5. doi: 10.1378/chest.94.4.811. Chest. 1988. PMID: 3139373

4

Antihypertensive therapy with prazosin in patients with left ventricular dysfunction. Improvement in cardiac performance and exercise tolerance.

Massie BM, Chan S. Massie BM, et al. Chest. 1981 Dec;80(6):692-7. doi: 10.1378/chest.80.6.692. Chest. 1981. PMID: 7307590

5

Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?

Lee CK, Chan SL, Chon HJ. Lee CK, et al. Among authors: chan sl. Cancers (Basel). 2022 Jun 30;14(13):3213. doi: 10.3390/cancers14133213. Cancers (Basel). 2022. PMID: 35804984 Free PMC article. Review.

6

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.

Kelley RK, Rimassa L, Cheng AL, Kaseb A, Qin S, Zhu AX, Chan SL, Melkadze T, Sukeepaisarnjaroen W, Breder V, Verset G, Gane E, Borbath I, Rangel JDG, Ryoo BY, Makharadze T, Merle P, Benzaghou F, Banerjee K, Hazra S, Fawcett J, Yau T. Kelley RK, et al. Among authors: chan sl. Lancet Oncol. 2022 Aug;23(8):995-1008. doi: 10.1016/S1470-2045(22)00326-6. Epub 2022 Jul 4. Lancet Oncol. 2022. PMID: 35798016 Free article. Clinical Trial.

7

One year clinical outcomes of Rutherford 6 chronic limb threatening ischemia patients undergoing lower limb endovascular revascularisation from Singapore.

Lee RE, Patel A, Soon SXY, Chan SL, Yap CJQ, Chandramohan S, Tay LHT, Chong TT, Tang TY. Lee RE, et al. Among authors: chan sl. CVIR Endovasc. 2022 Jul 6;5(1):32. doi: 10.1186/s42155-022-00306-1. CVIR Endovasc. 2022. PMID: 35792985 Free PMC article.

8

Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.

Lin H, Yip TC, Zhang X, Li G, Tse YK, Hui VW, Liang LY, Lai JC, Chan SL, Chan HL, Wong GL, Wong VW. Lin H, et al. Among authors: chan sl. Hepatology. 2022 Jul 5. doi: 10.1002/hep.32633. Online ahead of print. Hepatology. 2022. PMID: 35790018

9

Is hepatic resection justified for non-colorectal non-neuroendocrine liver metastases? A systematic review and meta-analysis.

Ng KKC, Cheng NMY, Lok HT, Kung JWC, Fung AKY, Chan SL. Ng KKC, et al. Among authors: chan sl. Surgeon. 2022 Jun 16:S1479-666X(22)00086-5. doi: 10.1016/j.surge.2022.05.003. Online ahead of print. Surgeon. 2022. PMID: 35718702 Review.

10

Skin grafts: A survey study of Australasian Mohs surgeons.

Chan SL, Cherian P. Chan SL, et al. Australas J Dermatol. 2022 Jun 4. doi: 10.1111/ajd.13871. Online ahead of print. Australas J Dermatol. 2022. PMID: 35661995 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results